News

A new channel for touch

Max Delbrück Center
By Max Delbrück Center
March 9, 2024

Every hug, every handshake, every dexterous act engages and requires touch perception. Therefore, it is essential to understand the molecular basis of touch.

“Until now, we had known that the ion channel – Piezo2 – is required for touch perception, but it was clear that this protein alone cannot explain the entirety of touch sensation,” says Gary Lewin, head of the Molecular Physiology of Somatic Sensation Lab at the Max Delbrück Center.

For over 20 years Lewin has been studying the molecular basis of the sensation of touch. He and his team have now discovered a new ion channel, named Elkin1, that plays a vital role in touch perception. This is only the second ion channel implicated in the touch perception. It is likely that the protein is directly involved in converting a mechanical stimulus, such as light touch, into an electrical signal. When Elkin1 is present, the receptors in the skin can transmit the touch signals via nerve fibers, to the central nervous system and brain. The researchers have published their findings in the journal Science.

Sampurna Chakrabarti & Felix Petermann, Max Delbrück Center / Amy Hulme, University of Wollongong
Left to right: Mouse neurons with the new ion channel Elkin1 (cyan), which is responsible for touch sensation, nucleus (yellow) and the already known ion channel Piezo2 (magenta). A petri dish with sensory neurons that are poked with the glass electrode. Induced human sensory neurons with the ion channel Elkin1 (cyan), nucleus (yellow) and Neurofilament 200 (magenta), that stains for large neurons that are involved in light touch

Lewin’s team came across Elkin1 a few years ago while investigating a malignant melanoma cell line. The researchers had found that the protein is required for sensing mechanical forces by these highly motile cancer cells. “Now we wanted to determine whether the same protein also plays a role in touch sensation” says Lewin.

Lack of Elkin1 reduces touch sensitivity

The researchers bred genetically modified mice that lacked the Elkin1 gene. They then conducted simple behavioral experiments that involved lightly brushing a cotton swab against the rodents’ hind paws. “Usually, normal mice react to the cotton swab 90% of the time,” Lewin said. “In contrast, mice lacking Elkin1 only reacted half of the time, indicating touch insensitivity”. Importantly, the rodents’ reaction to non-mechanical stimuli like temperature was not affected.

At the neuronal level, Sampurna Chakrabarti, a scientist in Lewin’s team, used the patch clamp method to record the electrical activity of sensory neurons in response to poking of the neuronal membrane. “Around half of the neurons in genetically modified mice lacking Elkin1 didn’t respond to mechanical stimuli, and no signal transmission occurred,” Chakrabarti said.

Further experiments confirmed that there were no signals relayed from the neuron’s receptor ending in the skin, on the first leg of the signals journey from skin to the spinal cord and brain. Furthermore, their Australian collaborators in the lab of Professor Mirella Dottori in the University of Wollongong tested whether Elkin1 in necessary for touch transduction in human sensory neurons grown in a petri dish from stem cells. Their findings also strongly suggest that Elkin1 could play a major role in human touch perception.

Katharina Bohm, Max Delbrück Center
Sampurna Chakrabarti at the microscope in in the Lewin Lab at the Max Delbrück Center.

The researchers assume that during normal signal transmission, Elkin1 and Piezo2 share roles in touch perception. They have also found evidence that Elkin1 may play a part in the transmission of painful mechanical stimuli. “If this is confirmed to be the case, we will have not only identified a second ion channel with an indispensable role in normal touch perception, but also a new potential target for treating chronic pain,” Lewin said.

This article was originally published on the Max Delbrück Center website. You can read the original here.

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Max Delbrück Center
Max Delbrück Center

The Max Delbrück Center for Molecular Medicine in the Helmholtz Association is a biomedical research institution located in Berlin-Buch and Mitte, Germany, where researchers from some 70 countries investigate the foundations of life from its most elementary building blocks to systems-wide mechanisms. 

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

The quest to treat and cure xerostomia
Interview

The quest to treat and cure xerostomia

July 23, 2024

Blake Warner, chief of the Salivary Disorders Unit at the NIH talks about his lab’s efforts to develop treatments for dry mouth.

There's more to blue cheese than just the stench
News

There's more to blue cheese than just the stench

July 21, 2024

Virginia Tech researchers discovered a way to synthesize a compound in the mold of blue cheese that has antibacterial and anticancer properties.

Engineering cells to broadcast their behavior can help scientists study their inner workings
News

Engineering cells to broadcast their behavior can help scientists study their inner workings

July 20, 2024

Researchers can use waves to transmit signals from the invisible processes and dynamics underlying how cells make decisions.

From the journals: JBC
Journal News

From the journals: JBC

July 19, 2024

Lung cancer cells resist ferroptosis. ORMDL3 in ulcerative colitis. Novel genetic variants in thyroid cancer. Read about these recent papers.

Seeking the sweet spot to beat a pig parasite
Journal News

Seeking the sweet spot to beat a pig parasite

July 16, 2024

Researchers extracted, separated and tested glycans from the porcine whipworm in an effort to determine the best way to develop treatments and vaccines.

Radioactive drugs strike cancer with precision
News

Radioactive drugs strike cancer with precision

July 14, 2024

The tumor-seeking radiopharmaceuticals are charting a new course in oncology, with promise for targeted treatments with fewer side effects.